MORRIS HOUSE GROUP PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: F85019 | LONDON, N17 6AA
Showing results 151-200 of 652
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Nortriptyline | 314 | 12.1K | £640 | +115.8% ▲ |
| Metoprolol tartrate | 311 | 6,314 | £1.0K | +513.1% ▲ |
| Chlorphenamine maleate | 309 | 21.2K | £594 | +180.0% ▲ |
| Progesterone | 308 | 17.0K | £4.2K | -26.4% ▼ |
| Fusidic acid | 308 | 6,585 | £835 | +141.2% ▲ |
| 308 | 1,129 | £40.0K | -43.5% ▼ | |
| Budesonide | 306 | 319 | £3.2K | +1,867.4% ▲ |
| Tiotropium bromide | 304 | 13.1K | £13.4K | +0.0% vs avg |
| Mometasone furoate | 303 | 18.7K | £1.8K | +126.6% ▲ |
| Budesonide | 294 | 1,166 | £13.2K | -45.8% ▼ |
| Clarithromycin | 291 | 5,531 | £1.3K | +18.6% ▲ |
| Clobetasol propionate | 290 | 17.3K | £1.4K | +112.6% ▲ |
| Prednisolone | 286 | 6,316 | £703 | +297.5% ▲ |
| Codeine phosphate | 280 | 31.4K | £1.1K | -61.0% ▼ |
| Peppermint oil | 278 | 15.7K | £1.3K | +249.4% ▲ |
| Estradiol with progestogen | 278 | 8,344 | £7.8K | -18.4% ▼ |
| Fenofibrate | 277 | 4,123 | £493 | +186.3% ▲ |
| Linagliptin/metformin | 277 | 10.5K | £6.0K | +722.5% ▲ |
| Alfuzosin hydrochloride | 276 | 9,128 | £3.4K | +285.8% ▲ |
| Valproic acid | 272 | 9,180 | £2.5K | +212.6% ▲ |
| Loperamide hydrochloride | 271 | 26.2K | £629 | +16.4% ▲ |
| Ispaghula husk | 270 | 15.2K | £2.9K | +105.0% ▲ |
| Dexamethasone | 268 | 1,415 | £882 | +55.9% ▲ |
| Timolol and bimatoprost | 265 | 3,204 | £4.9K | +74.6% ▲ |
| Bimatoprost | 263 | 3,973 | £2.3K | +76.9% ▲ |
| Eplerenone | 255 | 5,686 | £710 | -3.8% ▼ |
| Emulsifying wax | 254 | 141.5K | £1.0K | +1,985.2% ▲ |
| Clotrimazole | 254 | 7,300 | £445 | +162.1% ▲ |
| Carbimazole | 253 | 9,606 | £1.7K | +124.0% ▲ |
| Digoxin | 249 | 6,818 | £511 | -34.2% ▼ |
| Olopatadine | 249 | 1,585 | £1.6K | +467.6% ▲ |
| Vitamin B compound | 248 | 8,347 | £265 | +78.0% ▲ |
| Oxycodone hydrochloride | 247 | 24.2K | £6.7K | -3.5% ▼ |
| Moxonidine | 244 | 5,922 | £818 | +338.3% ▲ |
| Escitalopram | 244 | 8,610 | £489 | -14.3% ▼ |
| Mesalazine (Systemic) | 243 | 32.8K | £16.1K | +1.4% vs avg |
| Biphasic insulin aspart | 242 | 1,806 | £10.7K | +138.3% ▲ |
| Estriol | 238 | 3,615 | £3.6K | +11.8% ▲ |
| Lercanidipine hydrochloride | 236 | 8,741 | £931 | -61.8% ▼ |
| Cefalexin | 233 | 12.8K | £607 | +100.3% ▲ |
| Aciclovir | 231 | 8,329 | £438 | +55.3% ▲ |
| Emollient bath and shower preparations | 230 | 112.5K | £1.4K | +266.2% ▲ |
| Pravastatin sodium | 229 | 6,342 | £304 | -29.5% ▼ |
| Azithromycin | 228 | 6,717 | £2.1K | +79.9% ▲ |
| Ranolazine | 224 | 11.4K | £2.1K | +31.8% ▲ |
| Benzydamine hydrochloride | 222 | 23.9K | £714 | +187.0% ▲ |
| Desogestrel | 221 | 29.4K | £827 | -44.2% ▼ |
| Brinzolamide | 219 | 1,995 | £1.4K | +68.6% ▲ |
| Ivabradine | 217 | 8,176 | £2.5K | +128.3% ▲ |
| Ferrous sulfate | 216 | 11.1K | £365 | -58.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.